Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific Inc.

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Accounts Receivable, Net

Accounts Receivable, Net %Chg

Accounts Receivable, Net Common Size

Inventories

Inventories %Chg

Inventories Common Size

Deferred Tax Assets

Deferred Tax Assets %Chg

Deferred Tax Assets Common Size

Refundable Income Taxes

Refundable Income Taxes %Chg

Refundable Income Taxes Common Size

Contract Assets, Net

Contract Assets, Net %Chg

Contract Assets, Net Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Property, Plant and Equipment, Net

Property, Plant and Equipment, Net %Chg

Property, Plant and Equipment, Net Common Size

Acquisition-Related Intangible Assets, Net

Acquisition-Related Intangible Assets, Net %Chg

Acquisition-Related Intangible Assets, Net Common Size

Other Assets

Other Assets %Chg

Other Assets Common Size

Goodwill

Goodwill %Chg

Goodwill Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Short-Term Obligations and Current Maturities of Long-Term Obligations

Short-Term Obligations and Current Maturities of Long-Term Obligations %Chg

Short-Term Obligations and Current Maturities of Long-Term Obligations Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Accrued Payroll and Employee Benefits

Accrued Payroll and Employee Benefits %Chg

Accrued Payroll and Employee Benefits Common Size

Accrued Income Taxes

Accrued Income Taxes %Chg

Accrued Income Taxes Common Size

Contract Liabilities

Contract Liabilities %Chg

Contract Liabilities Common Size

Deferred Revenue

Deferred Revenue %Chg

Deferred Revenue Common Size

Other Accrued Expenses

Other Accrued Expenses %Chg

Other Accrued Expenses Common Size

Total Current Liabilities

Total Current Liabilities %Chg

Total Current Liabilities Common Size

Deferred Income Taxes

Deferred Income Taxes %Chg

Deferred Income Taxes Common Size

Other Long-Term Liabilities

Other Long-Term Liabilities %Chg

Other Long-Term Liabilities Common Size

Long-Term Obligations

Long-Term Obligations %Chg

Long-Term Obligations Common Size

Redeemable Noncontrolling Interest

Redeemable Noncontrolling Interest %Chg

Redeemable Noncontrolling Interest Common Size

Preferred Stock

Preferred Stock %Chg

Preferred Stock Common Size

Common Stock

Common Stock %Chg

Common Stock Common Size

Capital in Excess of Par Value

Capital in Excess of Par Value %Chg

Capital in Excess of Par Value Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Treasury Stock at Cost

Treasury Stock at Cost %Chg

Treasury Stock at Cost Common Size

Accumulated Other Comprehensive Income/(Loss)

Accumulated Other Comprehensive Income/(Loss) %Chg

Accumulated Other Comprehensive Income/(Loss) Common Size

Total Thermo Fisher Scientific Inc. Shareholders' Equity

Total Thermo Fisher Scientific Inc. Shareholders' Equity %Chg

Total Thermo Fisher Scientific Inc. Shareholders' Equity Common Size

Noncontrolling Interests

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accrued Expenses

Accrued Expenses %Chg

Accrued Expenses Common Size

Short-Term Debt

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Cash and Cash Equivalents	1,982	4,576	4,134	4,009	4,645	7,073
Cash and Cash Equivalents
Short-Term Investments	1,564	1,814	1,813	1,561	2,000	1,750
Short-Term Investments
Total Cash and Cash Equivalents	3,546	6,390	5,947	5,570	6,645	8,823
Accounts Receivable	8,911	8,594	8,455	8,191	8,255	7,943
Accounts Receivable, Net
Total Trade Receivables	8,911	8,594	8,455	8,191	8,255	7,943
Inventories	5,745	5,559	5,224	4,978	5,430	5,198
Inventories
Other Current Assets	4,092	4,040	3,753	3,399	3,452	3,512
Deferred Tax Assets
Refundable Income Taxes
Contract Assets, Net
Other Current Assets
Total Current Assets	22,295	24,584	23,378	22,137	23,783	25,476
Total Current Assets
Net Property, Plant & Equipment	10,177	9,635	9,331	9,306	9,412	9,282
Property, Plant and Equipment, Net
Net Intangible Assets	16,242	15,148	15,323	15,533	16,262	15,519
Acquisition-Related Intangible Assets, Net
Goodwill	49,287	47,249	46,493	45,853	46,726	43,843
Goodwill
Other Long-Term Assets	5,019	4,615	4,516	4,492	4,180	4,377
Other Assets
Total Assets	103,020	101,230	99,041	97,321	100,364	98,496
Total Assets

Liabilities	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Accounts Payable	3,120	2,980	3,049	3,079	2,606	2,547
Accounts Payable
Accrued Expenses	5,093	4,718	4,441	5,187	5,216	4,514
Accrued Payroll and Employee Benefits
Accrued Income Taxes
Other Accrued Expenses
Short-Term Debt	3,823	2,214	2,819	2,214	4,116	5,121
Short-Term Obligations and Current Maturities of Long-Term Obligations
Unearned Revenue	2,852	2,805	2,866	2,852	2,663	2,591
Contract Liabilities
Deferred Revenue
Total Current Liabilities	14,888	12,718	13,174	13,332	14,601	14,772
Total Current Liabilities
Long-Term Debt	31,857	33,015	31,370	29,061	31,197	30,284
Long-Term Obligations
Other Long-Term Liabilities	5,120	4,894	1,041	5,257	5,466	5,907
Deferred Income Taxes
Other Long-Term Liabilities
Total Long-Term Liabilities	36,977	37,909	32,411	34,318	36,663	36,191
Total Liabilities	51,865	50,627	45,585	47,650	51,264	50,963

Equity	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Preferred Stock	—	—	—	—	—	—
Preferred Stock
Common Stock	445	444	444	444	444	443
Common Stock
Treasury Stock	-22,310	-21,269	-21,269	-19,226	-18,227	-18,187
Treasury Stock at Cost
Additional Paid-in Capital	18,330	18,232	18,111	17,962	17,831	17,649
Capital in Excess of Par Value
Accumulated Other Comprehensive Income	-2,801	-2,797	-2,343	-2,697	-2,477	-2,413
Accumulated Other Comprehensive Income/(Loss)
Retained Earnings	57,354	55,901	54,447	53,102	51,421	49,940
Retained Earnings
Total Common Shareholders' Equity	51,018	50,512	49,390	49,584	48,992	47,432
Total Thermo Fisher Scientific Inc. Shareholders' Equity
Minority Interests and Other	136	91	95	87	107	103
Redeemable Noncontrolling Interest
Noncontrolling Interests
Total Shareholders' Equity	51,153	50,602	49,485	49,671	49,099	47,534
Total Equity
Redeemable Noncontrolling Interest
Total Liabilities and Shareholders' Equity	103,020	101,230	99,041	97,321	100,364	98,496
Total Liabilities, Redeemable Noncontrolling Interest and Equity